Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk
- Females and males who are carriers of deleterious mutations in the genes BRCA1 or
- Over age 18 and:
1. For women, less than 43
2. For men, less than 50.
- Received genetic testing and counseling for BRCA.
- Fluent in English.
- Patients who are currently under treatment (chemotherapy, radiation)
- Individuals who refuse to discuss reproductive issues.
- Unable to give informed consent due to physical, cognitive, or psychiatric disability
Type of Study:
Observational Model: Cohort, Time Perspective: Prospective
To explore the attitudes of BRCA1/2 mutation carriers about PGD/PND, most notably benefits and drawbacks, as well as ethical and emotional considerations;
Outcome Time Frame:
conclusion of study
Karen Hurley, PhD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
- Breast Cancer
- Ovarian Cancer
- Mutation carrier
- Breast Neoplasms
- Ovarian Neoplasms
|Memorial Sloan-Kettering Cancer Center||New York, New York 10021|